This research looks at the evolution of Pharma BPO to “As-a-Service”-a market that is increasingly agile, collaborative, and consumer-centric. The Publisher considers this transition in outsourcing a move to the As-a-Service Economy, placing increasing value on diverse talent, analytics, and collaboration, as well as increasingly on platform-based services.
Thus, in this Blueprint we use the 8 Ideals of the As-a-Service Economy as a significant element of our service provider assessment methodology. The eight ideals describe the operations of service buyers and service buyers in a business outcome-focused outsourcing partnership.
Two of the significant ways that pharmaceuticals companies “touch” consumers are in the R&D process and through sales and marketing. Along these lines, the scope of the Blueprint is business process support for industry-specific Pharmaceutical Research & Development and Commercial Services, including clinical data management, pharmacovigilance, regulatory support, consumer experience management, and sales and marketing.